pegulicianine acetate

pegulicianine acetate (LUMISIGHT) is an FDA-listed pharmaceutical active ingredient. Route of administration: intravenous. Current US regulatory status: approved.

LUMISIGHT is a marketed brand name for pegulicianine acetate. Check FDA Drugs@FDA for the current US label holder and prescribing information.

pegulicianine acetate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.